ATE165597T1 - 1-oleoylazacycloheptanon(2) enthaltende arzneimittel zur verstärkung des transports durch biologische membranen - Google Patents

1-oleoylazacycloheptanon(2) enthaltende arzneimittel zur verstärkung des transports durch biologische membranen

Info

Publication number: ATE165597T1
Authority: AT; Austria
Prior art keywords: oleoylazacycloheptanone; biological membranes; drugs containing; enhance transport; oleylazacycloheptan
Prior art date: 1992-01-20

Application number

AT92200159T

Other languages

English (en)

Inventor

Henry Ernest Bodde

Johannes Aaltje Bouwstra

Maria Helene Ponec

Ferdinand Spies

Klaus Sandrock

Original Assignee

Sanol Arznei Schwarz Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-01-20

Filing date

1992-01-20

Publication date

1998-05-15

1992-01-20 Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh

1998-05-15 Application granted granted Critical

1998-05-15 Publication of ATE165597T1 publication Critical patent/ATE165597T1/de

Links

239000012528 membrane Substances 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
241001465754 Metazoa Species 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
RAGAJCBPQFVUJU-KTKRTIGZSA-N 1-[(z)-octadec-9-enyl]azepan-2-one Chemical compound CCCCCCCC\C=C/CCCCCCCCN1CCCCCC1=O RAGAJCBPQFVUJU-KTKRTIGZSA-N 0.000 abstract 1
-1 1-oleylazacycloheptan-2-one compound Chemical class 0.000 abstract 1
229940122627 Membrane permeability enhancer Drugs 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
210000004955 epithelial membrane Anatomy 0.000 abstract 1
210000004379 membrane Anatomy 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
- C07D223/10—Oxygen atoms attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT92200159T 1992-01-20 1992-01-20 1-oleoylazacycloheptanon(2) enthaltende arzneimittel zur verstärkung des transports durch biologische membranen ATE165597T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP92200159A EP0552504B1 (de)	1992-01-20	1992-01-20	1-Oleoylazacycloheptanon(2) enthaltende Arzneimittel zur Verstärkung des Transports durch biologische Membranen
HK98104161A HK1005063A1 (en)	1992-01-20	1998-05-14	Pharmaceutical compositions containing 1-oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes

Publications (1)

Publication Number	Publication Date
ATE165597T1 true ATE165597T1 (de)	1998-05-15

Family

ID=26131246

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92200159T ATE165597T1 (de)	1992-01-20	1992-01-20	1-oleoylazacycloheptanon(2) enthaltende arzneimittel zur verstärkung des transports durch biologische membranen

Country Status (5)

Country	Link
EP (1)	EP0552504B1 (de)
AT (1)	ATE165597T1 (de)
DE (1)	DE69225306T2 (de)
ES (1)	ES2114907T3 (de)
HK (1)	HK1005063A1 (de)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1343426A (en) *	1971-05-07	1974-01-10	Dow Corning Tld	Acylated lactams
US4461638A (en) *	1975-06-19	1984-07-24	Nelson Research & Development Company	Delivery of plant nutrients
DE2616993A1 (de) *	1976-04-17	1977-10-27	Bayer Ag	Verfahren zum faerben von flaechengebilden
US4310525A (en) *	1981-01-23	1982-01-12	Nelson Research & Development Company	Method of treatment of inflammation
US4557934A (en) *	1983-06-21	1985-12-10	The Procter & Gamble Company	Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
EP0251425B1 (de) *	1986-04-03	1993-06-16	Hercon Laboratories Corporation	Artikel für die Verabreichung pharmakologisch aktiver Substanzen
US4755535A (en) *	1986-04-23	1988-07-05	Nelson Research & Development Co.	Compositions comprising 1-substituted azacycloalkenes
DE3778833D1 (de) *	1986-11-19	1992-06-11	Whitby Research Inc	Penetrationsverbesserer fuer die transdermale verabreichung von systemisch wirksamen arzneimitteln.
US4879275A (en) *	1987-09-30	1989-11-07	Nelson Research & Development Co.	Penetration enhancers for transdermal delivery of systemic agent
CA1334646C (en) *	1988-04-08	1995-03-07	James Vanolden Peck	Transdermal penetration enhancers

1992
- 1992-01-20 AT AT92200159T patent/ATE165597T1/de not_active IP Right Cessation
- 1992-01-20 DE DE69225306T patent/DE69225306T2/de not_active Expired - Fee Related
- 1992-01-20 ES ES92200159T patent/ES2114907T3/es not_active Expired - Lifetime
- 1992-01-20 EP EP92200159A patent/EP0552504B1/de not_active Expired - Lifetime
1998
- 1998-05-14 HK HK98104161A patent/HK1005063A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69225306T2 (de)	1998-12-17
EP0552504A1 (de)	1993-07-28
ES2114907T3 (es)	1998-06-16
EP0552504B1 (de)	1998-04-29
HK1005063A1 (en)	1998-12-18
DE69225306D1 (de)	1998-06-04

Similar Documents

Publication	Publication Date	Title
DE69317494D1 (de)	1998-04-23	Zusammensetzungen, die mono oder polyhydroxylierte Aminosäuren zur Behandlung des Insulinunabhängigen Diabetes Mellitus enthalten
NO952321D0 (no)	1995-06-13	Polypeptid, samt anti-HIV-preparat fremstilt fra dette
SE8700498D0 (sv)	1987-02-10	Novel pharmaceologically active compounds
NO981352D0 (no)	1998-03-25	Stabilt ekstrakt av Hypericum Perforatum L., fremgangsmåte for fremstilling derav og farmasöytiske sammensetninger
DE68909139D1 (de)	1993-10-21	Substanz FR901228 und deren Herstellung.
EP0221041A3 (de)	1987-10-28	Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
HUP9903536A2 (hu)	2000-03-28	Bázikus anyaggal stabilizált gyógyászati készítmények
HUP0000589A2 (hu)	2000-09-28	Vizes peptid készítmények
IT1255258B (it)	1995-10-20	Composizioni farmaceutiche per l'applicazione per via nasale.
DE50204946D1 (de)	2005-12-22	Dermal applizierbare flüssige formulierungen zur bekämpfung von parasitierenden insekten an tieren
ES8207169A1 (es)	1982-09-01	Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
EP0173092A3 (de)	1987-08-19	Antivirale Zubereitung
KR870700599A (ko)	1987-12-30	카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도
SE8404065D0 (sv)	1984-08-10	Novel biologically active compounds
DE3583916D1 (de)	1991-10-02	Waessrige arzneiformulierungen des piroxicammonohydrats.
ATE117684T1 (de)	1995-02-15	Heterocyclische verbindungen.
MD1360B2 (en)	1999-12-31	A fungicidal composition, process for control and prevention of plants Oomycetes infection
PH27446A (en)	1993-07-02	Compound with gastric acid inhibitory effect
EA199901012A1 (ru)	2000-08-28	Фармацевтические композиции на основе тизоксанида и нитазоксанида
SE8600658D0 (sv)	1986-02-14	Novel composition of matter
EP0806421A4 (de)	1998-04-15	Derivate der chinolincarbonsäure
ATE165597T1 (de)	1998-05-15	1-oleoylazacycloheptanon(2) enthaltende arzneimittel zur verstärkung des transports durch biologische membranen
DK0397646T3 (da)	1992-08-24	Farmaceutisk præparat til behandling af leversygdomme
DK344489D0 (da)	1989-07-12	Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
DK0853476T3 (da)	2002-07-29	Nimesulidholdigt farmaceutisk præparat til topisk anvendelse

Legal Events

Date	Code	Title	Description
1999-01-15	UEP	Publication of translation of european patent specification
2004-10-15	REN	Ceased due to non-payment of the annual fee